Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 2, 2008, Pages 130-134

  Goodgame, Boone ^a   Pillot, Giancarlo A ^a   Yang, Zhiyun ^b   Shriki, Jabi ^b   Meyers, Bryan F ^a,c   Zoole, Jennifer ^a   Gao, Feng ^a,c   Dehdashti, Farrokh ^b   Patterson, Alexander ^a,c   Siegel, Barry A ^a,b   Govindan, Ramaswamy ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d Division of Oncology   (United States)

Author keywords

Early stage; Imaging; Non small cell lung cancer; PET; Prognosis; Stage I; Surgery outcomes

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

EID: 40049084958     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318160c122     Document Type: Article

References (18)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
2. R Govindan N Page D Morgensztern Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database J Clin Oncol 24 2006 4539 4544
3. J Domont JC Soria T Le Chevalier Adjuvant chemotherapy in early-stage non-small cell lung cancer Semin Oncol 32 2005 279 283
4. JY Douillard R Rosell M De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727
5. T Winton R Livingston D Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597
6. The International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
7. GM Strauss J Herndon MA Maddaus Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633 (Meeting Abstract) J Clin Oncol 24 18 Suppl 2006 7007
8. RM Pieterman JWG van Putten JJ Meuzelaar Preoperative staging of non-small-cell lung cancer with positron-emission tomography N Engl J Med 343 2000 254 261
9. D Lardinois W Weder TF Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
10. H van Tinteren OS Hoekstra EF Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1392
11. G Pillot BA Siegel R Govindan Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review J Thorac Oncol 1 2006 152 159
12. DJ Raz AY Odisho BL Franc DM Jablons Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma J Thorac Cardiovasc Surg 132 2006 1189 1195
13. CF Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
14. R Kumar MR Nadig A Chauhan Positron emission tomography: clinical applications in oncology. Part 1 Expert Rev Anticancer Ther 5 2005 1079 1094
15. RJ Cerfolio AS Bryant B Ohja AA Bartolucci The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival J Thorac Cardiovasc Surg 130 2005 151 159
16. T Ohtsuka H Nomori KI Watanabe Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma Cancer 107 10 2006 2468 2473
17. K Higashi Y Ueda Y Arisaka 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med 43 2002 39 45
18. Y Sugawara LE Quint MD Iannettoni Does the FDG uptake of primary non-small cell lung cancer predict prognosis? A work in progress Clin Positron Imaging 2 1999 111 118